BioCentury | Jun 10, 2013
Company News

Astellas, Tecnofarma International Ltd. sales and marketing update

...Astellas granted Tecnofarma exclusive rights to distribute prostate cancer drug Xtandi enzalutamide in Latin America, excluding...
...commercialize Xtandi in 2009 (see BioCentury, Nov. 2, 2009). Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Tecnofarma...
BioCentury | Aug 3, 2009
Company News

Tecnofarma S.A. de CV, Valeant Pharmaceuticals International deal

...In a bid to grow its branded generics business, Valeant will acquire generics company Tecnofarma for...
...antibiotics and drugs for pain and cancer. The deal is expected to close in September. Tecnofarma S.A. de CV...
BioCentury | Jul 27, 1998
Company News

Merck KGaA, Tecnofarma A/S sales and marketing update

...Latin America for Tecnofarma's eutrophine growth hormone and Intermax alpha interferon. Merck KGaA, Darmstadt, Germany Tecnofarma...
BioCentury | Jun 30, 1997
Company News

Sequus, Tecnofarma S.A.I.C.F. and Laboratorios Raffo S.A. sales and marketing update

...patients who have failed conventional systemic antifungal therapy. Sequus Pharmaceuticals Inc. (SEQU), Menlo Park, Calif. Tecnofarma...
Items per page:
1 - 4 of 4
BioCentury | Jun 10, 2013
Company News

Astellas, Tecnofarma International Ltd. sales and marketing update

...Astellas granted Tecnofarma exclusive rights to distribute prostate cancer drug Xtandi enzalutamide in Latin America, excluding...
...commercialize Xtandi in 2009 (see BioCentury, Nov. 2, 2009). Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Tecnofarma...
BioCentury | Aug 3, 2009
Company News

Tecnofarma S.A. de CV, Valeant Pharmaceuticals International deal

...In a bid to grow its branded generics business, Valeant will acquire generics company Tecnofarma for...
...antibiotics and drugs for pain and cancer. The deal is expected to close in September. Tecnofarma S.A. de CV...
BioCentury | Jul 27, 1998
Company News

Merck KGaA, Tecnofarma A/S sales and marketing update

...Latin America for Tecnofarma's eutrophine growth hormone and Intermax alpha interferon. Merck KGaA, Darmstadt, Germany Tecnofarma...
BioCentury | Jun 30, 1997
Company News

Sequus, Tecnofarma S.A.I.C.F. and Laboratorios Raffo S.A. sales and marketing update

...patients who have failed conventional systemic antifungal therapy. Sequus Pharmaceuticals Inc. (SEQU), Menlo Park, Calif. Tecnofarma...
Items per page:
1 - 4 of 4